is commonly treated with anti-glaucoma medications. Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the intraocular pressure (IOP) and medication use in NTG.
In the initially recruited 46 NTG subjects, one was deceased prior to the 12-month follow-up, two needed a secondary SLT treatment within the first 12 months, and two had a phacoemulsification ...
A 2022 ophthalmology study showed that selective laser trabeculoplasty, another procedure in this legislation, provided better long-term treatment for glaucoma than eye drops. More than 3 ...